drugset / Trial / NCT06543628

Evaluation of Tadalafil Combined With LIPUS for Treating Erectile Dysfunction

NCT06543628

RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to evaluate the clinical efficacy and histological changes of tadalafil combined with low-intensity pulsed ultrasound (LIPUS) in patients with erectile dysfunction (ED) through a randomized controlled trial.

Timeline

Start
2024-08-11
Primary completion
2025-03-01
Completion
2025-03-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 5 mg

Indications